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Abstract
Background: Anal smears are increasingly being used as a screening test for anal squamous
intraepithelial lesions (ASILs). This study was undertaken to assess the usefulness and limitations of
anal smears in screening for ASILs.
Methods: The cytomorphological features of 200 consecutive anal smears collected in liquid
medium from 198 patients were studied and findings were correlated with results of surgical
biopsies and/or repeat smears that became available for 71 patients within six months.
Results: Adequate cellularity was defined as an average of 6 or more nucleated squamous cells/
hpf. A glandular/transitional component was not required for adequacy. Dysplastic cells, atypical
parakeratotic cells and bi/multinucleated cells were frequent findings in ASIL while koilocytes were
infrequent. Smears from LSIL cases most frequently showed mildly dysplastic and bi/multinucleate
squamous cells followed by parakeratotic cells (PK), atypical parakeratotic cells (APK), and
koilocytes. HSIL smears contained squamous cells with features of moderate/severe dysplasia and
many APKs. Features of LSIL were also found in most HSIL smears.
Conclusions: In this study liquid based anal smears had a high sensitivity (98%) for detection of
ASIL but a low specificity (50%) for predicting the severity of the abnormality in subsequent biopsy.
Patients with cytologic diagnoses of ASC-US and LSIL had a significant risk (46–56%) of HSIL at
biopsy. We suggest that all patients with a diagnosis of ASC-US and above be recommended for
high resolution anoscopy with biopsy.
Note
For corresponding Editorial, please see Leiman, 2005 [25]
Background
The incidence of anal squamous carcinoma and its precur-
sor lesions has increased in recent years particularly
among men having sex with men (MSM) [1]. Prior to the
human immunodeficiency virus (HIV) epidemic the inci-
dence of anal cancer in this high risk population was esti-
mated at 36.9 per 100,000 [2], similar to the incidence of
cervical cancer prior to adoption of routine cervical cytol-
ogy screening programs. Among MSM, the incidence of
anal cancer in HIV positive individuals has been esti-
mated to be twice that in HIV negative individuals [3,4].
The American Cancer Society projected that about 4,010
new cases of anal cancer would be diagnosed in the
United States in 2004, (up from 3,400 cases in 2000) and
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that about 580 persons would die of the disease during
the year [5].
Anal and cervical lesions share many histological and
pathological characteristics including the implication of
human papilloma virus (HPV) in the pathogenesis of pre-
cursor squamous intraepithelial lesions and invasive can-
cer [6]. Just as routine Pap smear screening has
dramatically reduced the incidence of cervical cancer, it is
anticipated that screening populations at high risk for
anal squamous intraepithelial lesions (ASILs) will reduce
the incidence of anal cancer in these individuals. Accord-
ingly we and other laboratories are experiencing a sub-
stantial increase in the number of anal smears submitted
for cytologic evaluation. This study was performed to
assess the usefulness and limitations of anal smears in
screening for ASILs.
Materials And Methods
After approval from the IRB, 200 consecutive anal smears
submitted from 198 patients were retrieved from the files
of the pathology department at Cedars-Sinai Medical
Center. The samples had all been collected from the anal
canal using the Rovers endocervex brush (Therapak Corp.,
Irwindale, CA, distributor for Rovers Medical Devices,
OSS, The Netherlands), the Digene cervical sampler brush
(Digene Corp. Gaithersburg, MD), or the brush from
SurePath sample collection kit (TriPath Care Tech, TriPath
Imaging, Inc. Burlington, NC) (Figure 1) and submitted in
liquid medium (SurePath™, TriPath Imaging™, Burling-
ton, NC). All of the patients were males between the ages
of 24 and 67 years (mean: 40.7 yrs., median: 41 yrs). HIV
status was available for 79 patients, 37 of whom were HIV
positive.
Retrieved slides were reviewed by three cytopathologists
and evaluated for cellularity and presence of anucleated
squamous cells, glandular/ transitional cells (G/TZ), par-
akeratotic cells (PKs), atypical parakeratotic cells (APKs),
koilocytes, binucleated and/or multinucleated squamous
cells (B/MSCs), and dysplastic cells. The number of cells
exhibiting each of these morphologic features was
recorded as none, rare (no more than 2 cells/smear), and
present (3 or more cells/smear). For this study cellularity
was defined as the average number of nucleated squa-
mous cells per 40x high power field (nsc/hpf) calculated
by counting 10 hpfs. All of the anal smears had been
reported using a modified Bethesda 2001 System termi-
nology recommended for cervical smears [7]. After dis-
crepancies were resolved by re-evaluation, discussion, and
concurrence by at least two cytopathologists, the diag-
noses were as follows: unsatisfactory due to insufficient
cellularity (17 smears), negative for intraepithelial lesion
or malignancy (NIL; 58 smears), atypical squamous cells
of undetermined significance (ASC-US; 42 smears), low
grade squamous intraepithelial lesion (LSIL; 59 smears),
atypical squamous cells of undetermined significance can-
not exclude high grade squamous intraepithelial lesion
(ASC-H; 17 smears), and high grade squamous intraepi-
thelial lesion (HSIL; 7 smears).
Revised cytologic diagnoses were correlated with concur-
rent and/or follow up tissue biopsies or with repeat anal
smears all obtained within six months. Statistical analyses
were performed using the Fishers Test. A two sided p value
of 0.05 was considered as significant [8].
Results
Cellularity
For purposes of this study we required an average of at
least 6 nsc/hpf for cellularity to be considered adequate.
This was based on the observation that only smears aver-
aging 6 or more nsc/hpf included abnormal cytologic
diagnoses ranging from ASC-US through HSIL whereas
smears averaging 5 or fewer nsc/hpf were either NIL or
ASC-US. 91% (181) of the 200 smears contained an aver-
age of 6 or more nsc/hpf. Of the 19 cases that averaged
fewer than 6 nsc/hpf, 17 were designated as unsatisfactory
and excluded from the study while two that contained
atypical squamous cells were reported as ASC-US and
included in the subsequent morphologic analysis. Of
note, all of the 7 smears with HSIL and 16/17 smears with
ASC-H were cellular with an average of 8 or more nsc/hpf.
Collection brushes Figure 1
Collection brushes. A. Brush from SurePath sample collec-
tion kit (TriPath Care Tech, TriPath Imaging, Inc. Burlington, 
NC.) B. Rovers endocervex brush (Therapak Corp., Irwin-
dale, CA, distributor for Rovers Medical Devices, OSS, The 
Netherlands) C. Digene cervical sampler brush (Digene 
Corp., Gaithersburg, MD)
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Anucleated squamous cells
Anucleated squamous cells were present in smears that
were NIL and in smears with diagnoses ranging from ASC-
US to HSIL. There were numerous anucleated squamous
cells in 7 smears that were reported as unsatisfactory.
Among the abnormal smears, neither the presence nor
number of anucleated squamous cells correlated with
cytologic diagnosis.
Glandular/transitional cells
Three or more groups of G/TZ were present in 56% (103)
of the smears while rare G/TZ were seen in an additional
18% (33) smears. Of these smears 68% (93/136) had an
abnormal cytologic diagnosis (27 ASC-US, 45 LSIL, 14
ASC-H, 7 HSIL). In comparison 26% (47) of smears con-
tained no G/TZ of which 68% (32) were reported as
abnormal (15 ASC-US, 14 LSIL, 3 ASC-H) suggesting that
the presence of glandular cells did not facilitate abnormal
diagnoses. Again all of the 7 smears with HSIL and 12/17
smears with ASC-H contained 3 or more groups of glan-
dular cells, while two smears with ASC-H contained only
rare glandular cells.
Parakeratotic cells
Parakeratotic cells were observed in 71% (130) of the
smears in the study. Parakeratotic cells were observed in
negative (63%, 37/58) as well as in abnormal (74%, 93/
125) cases. In negative cases rare parakeratotic cells were
observed more often (in 72%, 27 cases) whereas in smears
with epithelial abnormalities presence of rare parakera-
totic cells and frequent (>3) parakeratotic cells were about
evenly distributed (46%, 43 cases vs 54%, 50 cases).
Atypical parakeratotic cells
APKs were found in 40% (74) of the 183 smears. The
number of cases showing APKs increased with the severity
of the dysplasia. There were 3 or more APKs in 22% (41)
of the smears constituting 7% of ASC-US, 41% of LSIL,
53% of ASC-H and 71% of HSIL cases. Rare APKs were
found in 18% (33) of the smears that were interpreted as
ASC-US or above. APKs were not found in any of the neg-
ative smears and were seen in 72% of the SIL smears.
Koilocytes
Classical koilocytes were infrequent (17%) in all diagnos-
tic categories (Figure 2). Three or more koilocytes were
seen in only 10% (6/59) of the LSIL smears and in 6% (1/
17) of the ASC-H cases. Rare koilocytes were found in 2%
(1/42) of the ASC-US, 20% (12/59) of the LSIL, and 14%
(1/7) of the HSIL smears.
Multinucleation
B/MSCs were observed more frequently in abnormal
smears – 81% (101/125) as compared to 33% (19/58) of
the NIL smears (Figure 3). Among the abnormal cases, 3
or more B/MSCs were present in 59% (74/125 cases)
which included 31% (13/42) of ASC-US, 75% (44/59) of
LSILs, 76% (13/17) of ASC-Hs, and 43% (4/7) of HSILs.
Rare B/MSCs were observed in the remaining 41% cases
which included 31% (13/42) of ASC-US, 15% (9/59) of
LSILs, 18% (3/17) of ASC-Hs, and 29% (2/7) of HSILs.
Although B/MSCs were observed in some smears with
cytologic diagnosis of NIL, their presence correlated
Low grade squamous intraepithelial lesion with typical  koilocyte Figure 2
Low grade squamous intraepithelial lesion with typical koilo-
cyte. Papanicolaou stain × 40×
Low grade squamous intraepithelial lesion with bi- and multi- nucleated cells Papanicolaou stain × 40× Figure 3
Low grade squamous intraepithelial lesion with bi- and multi-
nucleated cells Papanicolaou stain × 40×CytoJournal 2005, 2:4 http://www.cytojournal.com/content/2/1/4
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significantly with an abnormal cytologic diagnosis (p <
0.0001).
Dysplastic squamous cells
84% (50/59) of the smears diagnosed as LSIL contained 3
or more squamous cells with features of mild dysplasia
(Figure 4), 6 cases had rare mildly dysplastic cells, and 3
smears contained typical koilocytes but no dysplastic
cells. Three or more cells exhibiting moderate/severe dys-
plasia were present in all smears diagnosed as HSIL (Fig-
ure 5). ASC-H cases contained 2 or fewer abnormal cells
with features of high grade dysplasia in 5 cases, whereas
the remaining showed small cells with dense cytoplasm
and atypical nuclei raising the possibility of atypical meta-
plastic and/or atypical parakeratotic cells. 71% of the
smears diagnosed as ASC-H (12/17) and HSIL (5/7) also
contained 3 or more mildly dysplastic cells and rare
mildly dysplastic cells were found in an additional 4 ASC-
H and 2 HSIL smears.
Table 1 summarizes the frequency of these cytomorpho-
logic features with respect to the cytodiagnostic categories.
The most frequent findings in smears diagnosed as LSIL
were mildly dysplastic and B/MSCs followed by PKs,
APKs, and koilocytes. Smears diagnosed as HSIL
contained multiple squamous cells with features of mod-
erate/ severe dysplasia, many APKs, and varying numbers
of PKs, B/MSCs, and koilocytes. Each of the smears
diagnosed as HSIL also contained some mildly dysplastic
cells but classical koilocytes were infrequent.
Correlation with follow up diagnosis
Within six months of the index anal smear, follow up con-
sisting of 56 biopsies and 15 smears became available for
39% (71) of the 183 smears constituting 39% (181) of the
patients in the study. As shown in Table 2, 86% (57 of 66)
smears diagnosed as ASC-US or above were confirmed as
abnormal on subsequent biopsy (54) or repeat smear
(12). Follow up for 11 smears diagnosed as ASC-US
yielded 4 negative, 2 AIN I, 1 AIN II, and 4 AIN III. Five
smears diagnosed as LSIL were negative, 11 were AIN I,
and 20 were AIN II-III on subsequent follow up. HPV
Digene Hybrid Capture II assay was performed on 3 of the
4 ASC-US cases and 3 of the 5 LSIL cases that were nega-
tive on follow up. The 3 ASC-US cases tested negative for
HPV DNA. The 3 LSIL cases tested positive for both low
and high risk HPV DNA and repeat smears at 8 and 10
months respectively showed persistent LSIL in 2 of these
cases. Biopsy confirmed 100% of the HSIL diagnoses and
76% (13/17) of the ASC-H diagnoses. Two cases diag-
nosed as ASC-H on cytology showed AIN I on biopsy; no
follow up became available for the remaining 2 cases that
had been diagnosed as ASC-H. Only 5 smears diagnosed
as NIL had follow up biopsy; 4 were negative and 1
showed AIN II.
Discussion
ASIL presents unique challenges in diagnosis and clinical
management. By decreasing deaths from opportunistic
infections, widespread use of highly active antiretroviral
agents and other therapies have done much to improve
Low grade squamous intraepithelial lesion with mildly dyplas- tic cells Papanicolaou stain × 40× Figure 4
Low grade squamous intraepithelial lesion with mildly dyplas-
tic cells Papanicolaou stain × 40×
A. & B. High grade squamous intraepithelial lesion showing  small to medium severely dysplastic cells Figure 5
A. & B. High grade squamous intraepithelial lesion showing 
small to medium severely dysplastic cells. Papanicolaou stain 
× 40×
A BCytoJournal 2005, 2:4 http://www.cytojournal.com/content/2/1/4
Page 5 of 7
(page number not for citation purposes)
survival of HIV infected individuals. However, because
these therapies do not impact the incidence of HPV infec-
tions or malignancies in these individuals, the increased
life span of HIV+ individuals probably provides the pri-
mary explanation for the rapid and continuing increase in
HPV associated AIN that these individuals are experienc-
ing [9-12]. With the help of cytology screening, anal squa-
mous carcinoma may be one of very few preventable
malignancies in these individuals.
Anal cytology has been shown to be a cost-effective
screening method for detection of ASIL in populations at
high risk for anal carcinoma[13]. To date there are few
studies that address selected cytomorphologic features
and diagnostic limitations associated with anal cytology.
Based on the follow up available in our study, a diagnosis
of ASC-US and above detected 86% of AINs. If one
includes the 5 LSIL smears that were negative on follow up
biopsy (all 5 confirmed as LSIL on smear review by three
cytopathologists, 3 additionally confirmed by repeat
smears testing and/or HPV DNA), then the detection rate
increase to 94%. Only one AIN lesion was NIL on cytol-
ogy. This further confirms that anal smears are a sensitive
means for detection of ASIL with a sensitivity of 98%.
However, as seen in our study anal cytology was a poor
predictor of the severity of AIN lesions and frequently
underdiagnosed these lesions. Specificity was calculated
at only 50%. Follow up for 5 of 11 (46%) ASC-US smears
showed AIN II-III and follow up in 20 of 36 (56%) LSIL
smears showed AIN II-III. Conversely, of the 43 cases with
AIN II-III on biopsy, only 4 (9%) had been correctly
diagnosed as HSIL and only 13 (30%) had been reported
as ASC-H while 26 (60%) had been reported as LSIL or
below on cytology. The percent cases correctly diagnosed
as HSIL may be improved from 9 to 13 (21%) if the 5
ASC-H cases with only 1–2 high grade dysplastic cells in
the smear were also reported as HSIL. However, this is dif-
ficult in "real life" particularly since ASC-H cases
frequently also contain atypical parakeratotic cells. In
summary, cytology underdiagnosed 35% (25) of the 71
Table 1: Frequency and distribution of cytologic findings in anal smears
Cytologic 
diagnosis (n = 183)
Cytologic features
Parakeratosis Atypical 
Parakeratosis
Koilocytes Bi/Multi-nucleation Mild dysplasia Moderate-severe 
dysplasia
NIL (n = 58) + - - + - -
A S C - U S  ( n  =  4 2 ) +++++-
LSIL (n = 59) ++ ++ + +++ +++ -
ASC-H (n = 17) ++ ++ + +++ ++ +
HSIL (n = 7) ++ +++ + ++ ++ +++
+, ++, +++ indicates feature is present in 3 or more cells in 1–33%, 34–74%, or >75% of cases, respectively
n = number of cases
Table 2: Follow up diagnoses at 6 months
Cytologic diagnoses Diagnosis at followup‡
Negative AIN I AIN II AIN III
NIL (5) 4 - 1 -
ASC-US (11) 4† 2 1 4
LSIL (36) 5* 11 17 3
A S C - H  ( 1 5 ) -258
HSIL (4) - - 1 3
Total cases (71) 13 15 25 18
†3 of these cases tested negative for HPV DNA utilizing Digene HCII
*3 of these cases tested positive for high and low risk HPV DNA utilizing Digene HCII and 2 of these cases showed persistent LSIL on follow up at 
8 and 10 months respectively
‡Follow up constitutes a composite of 56 biopsies and 15 repeat smearsCytoJournal 2005, 2:4 http://www.cytojournal.com/content/2/1/4
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cases with follow up. There were no high-grade overcalls.
In our study, a diagnosis of ASC-H or HSIL accurately pre-
dicted the presence of AIN II-III in 90% of cases. However,
a cytologic diagnosis of ASC-US or LSIL also held a 46–
56% chance that a high-grade AIN would be present on
biopsy. This figure is high when compared to cervical
cytology where ASC-US and LSIL have been associated
with only a 5–17% chance of HSIL on biopsy [14,15].
Prior experience with anal smears as documented in the
literature[16,17] reveals that anal smears have low sensi-
tivity and specificity for AIN lesions with poor detection
of high grade lesions. Defining abnormal cytology to
include ASC-US and ASIL, Palefsky et al [16] reported the
sensitivity of anal cytology for detection of biopsy-proven
ASIL to be 69% in 407 HIV-positive and 47% in 251 HIV-
negative homosexual or bisexual men. The authors also
note that the grade of disease on anal cytology did not
always correspond to the histologic grade, a finding simi-
lar to ours. Anal smears were obtained by dacron swabs in
this study. Similarly, Panther et al [18] reported that anal
cytology is an inaccurate predictor of the presence of HSIL,
regardless of HIV status. The authors analyzed 153 paired
specimens of anal cytology and anal biopsies or surgical
excisions and obtained a sensitivity of only 47% for detec-
tion of a high-grade lesion (ASIL II, III, or invasive squa-
mous cell cancer). Moreover, in their study a cytologic
diagnosis of ASC-US (n = 30) was associated with a broad
distribution of histologic diagnoses (7 NIL, 11 AIN I, 7
AIN II, or 5 AIN III). Thus, the authors concluded that the
presence of any abnormal anal cytologic finding indicates
a potential for HSIL on histologic examination. Our study
supports this finding. We attribute the higher detection
rate for AIN in our study to the collection of specimens in
liquid medium using brushes resulting in greater cellular-
ity of our specimens. Liquid-based preparations have also
been shown to virtually eliminate poor fixation/air drying
artifacts and markedly reduce obscuring fecal contamina-
tion thereby providing superior quality material com-
pared to conventional smears [19,20]. A comparable
sensitivity level of 92% has been reported by Friedlander
et al [17] utilizing thin prep liquid based collection
medium (Cytyc, Boxborough, MA).
There is a paucity of literature regarding criteria for ade-
quate anal cytology samples. The 2001 Consensus Confer-
ence in Bethesda [7] suggested that 3 – 6 nsc/hpf may be
considered adequate for SurePath preparations. An aver-
age of 6 or more nsc/hpf detected 123 of the 125 of the
abnormal cases in this study (2 undetected ASC-US had
lower cellularity). Moreover, although smears with diag-
noses of HSIL or ASC-H contained 8 or more nsc/hpf, no
statistical association was observed between smear cellu-
larity and undetected HSIL lesions. Thus, for SurePath
preparations an average of 6 or more nsc/hpf is recom-
mended as an adequacy guideline.
The presence of G/TZ was not a prerequisite for adequacy
in our study. Smears with and without G/TZ detected the
same percentage (68%) of abnormal cases. Although
most HSIL and ASC-H smears contained 3 or more groups
of G/TZs, absence of G/TZ did not correlate statistically
with undetected AIN II/III lesions. Thus we do not con-
sider the presence of G/TZ as essential for adequacy, a sit-
uation analogous to cervical Pap smears [7,21,22].
Interestingly, we did not encounter any cases of atypical
glandular cells of undetermined significance, glandular
dysplasia, or adenocarcinoma in our smears. At this time,
it is not clear whether individuals at increased risk for ASIL
are also at increased risk for anorectal glandular dysplasia
and adenocarcinoma.
On review of the morphological features of AIN lesions in
cytology smears, we noticed some salient features. Dys-
plastic cells were the most reliable indicators of ASIL/AIN.
Typical koilocytes were infrequent, observed in only 17%
of SILs, a finding previously observed by Darragh et al
[19] who reported that koilocytes were (a) less frequently
observed in anal smears than in cervical smears and (b)
absent in some smears that were diagnostic for AIN. APKs,
on the other hand, were frequent, present in 72% SILs,
and helpful in the diagnosis of ASIL. They were observed
most frequently and in greatest numbers in HSIL lesions.
Friedlander et al [17], in a review of 70 ThinPrep anal
smears for selected cytomorphologic features reported
APKs in 62% and koilocytes in 21% of smears. They
emphasized the "ubiquitous presence of atypical kerati-
nized squamous cells" and caution against overinterpreta-
tion of these cells as indicative of HSIL or squamous
carcinoma. B/MSCs were also good indicators of abnor-
mal smears. Although, they may be seen in small numbers
in negative smears, when present in large numbers, B/
MSCs should trigger a search for ASIL. Parakeratotic cells,
although frequently observed were not helpful in the
diagnosis of ASIL, a finding supported by Friedlander et al
[17] who observed parakeratotic cells in 84% of their
study cases. Similar studies in cervical smears have shown
that parakerstosis in otherwise negative Pap smears, is not
a reliable marker for cervical intraepithelial neoplasia
[23,24].
In ASC-H and HSIL, high grade squamous cells are usually
small, found as single cells or small sheets admixed with
mildly dysplastic cells and atypical parakeratotic cells.
Careful scrutiny is required to not miss these high grade
lesions.
Our experience with anal cytology also indicates that
other infectious agents are rarely diagnosed in analCytoJournal 2005, 2:4 http://www.cytojournal.com/content/2/1/4
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smears. Candida was present in one case. Herpes or tri-
chomonads were not seen.
Conclusions
To summarize, liquid based anal smears provide a sensi-
tive method for screening populations at increased risk for
ASIL but have a low specificity for predicting the severity
of the lesion. Patients with cytologic diagnosis of ASC-US
and LSIL have a significant risk of having HSIL and should
be recommended for high resolution anoscopy with
biopsy.
Competing interests
The author(s) declare that they have no competing
interests.
Authors' contributions
SA participated in the acquisition, analysis and interpreta-
tion of data and helped to draft the manuscript.
AEW participated in its design, in the acquisition, analysis
and interpretation of data and helped to write the
manuscript.
PT participated in its design, in the acquisition, analysis
and interpretation of data and helped to write the
manuscript.
SB conceived of the study, participated in its design, in the
acquisition, analysis and interpretation of data and
helped to write the manuscript.
All authors read and approved the final manuscript.
Acknowledgements
Co-editors of CytoJournal Vinod B. Shidham, MD, FRCPath, FIAC and Bar-
bara F. Atkinson, MD thank: the academic editor Gladwyn Leiman MBBCh, 
FIAC, FRCPath, Director of Cytopathology, Fletcher-Allen Health Care, 
Professor of Pathology, University of Vermont, 111 Colchester Avenue, 
Burlington, VT 05401, USA Gladwyn.Leiman@vtmednet.org for organizing 
and completing the peer-review process for this manuscript.
References
1. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wur-
scher MA, Carter JJ, Porter PL, Galloway DA, McDougall JK: Human
papillomavirus, smoking, and sexual practices in the etiology
of anal cancer. Cancer 2004, 101:270-280.
2. Daling JR, Weiss NS, Klopfenstein LL, Cochran LE, Chow WH,
Daifuku R: Correlates of homosexual behavior and the inci-
dence of anal cancer. Jama 1982, 247:1988-1990.
3. Melbye M, Cote TR, Kessler L, Gail M, Biggar RJ: High incidence of
anal cancer among AIDS patients. The AIDS/Cancer Work-
ing Group. Lancet 1994, 343:636-639.
4. Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe
ES, Biggar RJ: Spectrum of AIDS-associated malignant
disorders. Lancet 1998, 351:1833-1839.
5. American Cancer Society I: All about anal cancer. wwwcancerorg/
docroot/CRI/CRI_2xasp?sitearea=&dt=47 2004.
6. Palefsky JM: Anal squamous intraepithelial lesions in human
immunodeficiency virus-positive men and women.  Semin
Oncol 2000, 27:471-479.
7. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M,
Raab S, Sherman M, Wilbur D, Wright TJ, Young N: The 2001
Bethesda System: terminology for reporting results of cervi-
cal cytology. Jama 2002, 287:2114-2119.
8. Uitenbroek DG: SISA-Binomial. <http://homeclaranet/sisa/binomial-
htm>(1 Jan 2002) 1997.
9. Ortholan C, Francois E, Gerard JP: [Preneoplastic anal lesions
and anal canal carcinoma]. Bull Cancer 2003, 90:405-411.
10. Chin-Hong PV, Palefsky JM: Natural history and clinical manage-
ment of anal human papillomavirus disease in men and
women infected with human immunodeficiency virus.  Clin
Infect Dis 2002, 35:1127-1134.
11. Kreuter A, Reimann G, Esser S, Rasokat H, Hartmann M, Swoboda J,
Conant MA, Tschachler E, Arasteh K, Altmeyer P, Brockmeyer NH:
[Screening and therapy of anal intraepithelial neoplasia
(AIN) and anal carcinoma in patients with HIV-infection].
Dtsch Med Wochenschr 2003, 128:1957-1962.
12. Horster S, Thoma-Greber E, Siebeck M, Bogner JR: Is anal carci-
noma a HAART-related problem?  Eur J Med Res 2003,
8:142-146.
13. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML,
Palefsky JM: The clinical effectiveness and cost-effectiveness of
screening for anal squamous intraepithelial lesions in homo-
sexual and bisexual HIV-positive men.  Jama 1999,
281:1822-1829.
14. Wright TCJ, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ: 2001 Con-
sensus Guidelines for the management of women with cervi-
cal cytological abnormalities. Jama 2002, 287:2120-2129.
15. The ASCUS-LSIL Triage Study (ALTS) Group : A randomized trial
on the management of low-grade squamous intraepithelial
lesion cytology interpretations.  Am J Obstet Gynecol 2003,
188:1393-1400.
16. Palefsky JM, Holly EA, Hogeboom CJ, Berry JM, Jay N, Darragh TM:
Anal cytology as a screening tool for anal squamous intraep-
ithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol 1997,
14:415-422.
17. Friedlander MA, Stier E, Lin O: Anorectal cytology as a screening
tool for anal squamous lesions: cytologic, anoscopic, and his-
tologic correlation. Cancer 2004, 102:19-26.
18. Panther LA, Wagner K, Proper J, Fugelso DK, Chatis PA, Weeden W,
Nasser IA, Doweiko JP, Dezube BJ: High resolution anoscopy
findings for men who have sex with men: inaccuracy of anal
cytology as a predictor of histologic high-grade anal intraep-
ithelial neoplasia and the impact of HIV serostatus. Clin Infect
Dis 2004, 38:1490-1492.
19. Darragh TM, Jay N, Tupkelewicz BA, Hogeboom CJ, Holly EA, Palef-
sky JM: Comparison of conventional cytologic smears and
ThinPrep preparations from the anal canal. Acta Cytol 1997,
41:1167-1170.
20. Sherman ME, Friedman HB, Busseniers AE, Kelly WF, Carner TC,
Saah AJ: Cytologic diagnosis of anal intraepithelial neoplasia
using smears and cytyc thin-preps. Mod Pathol 1995, 8:270-274.
21. Birdsong GG: Pap smear adequacy: Is our understanding sat-
isfactory...or limited? Diagn Cytopathol 2001, 24:79-81.
22. Baer A, Kiviat NB, Kulasingam S, Mao C, Kuypers J, Koutsky LA: Liq-
uid-based Papanicolaou smears without a transformation
zone component: should clinicians worry? Obstet Gynecol 2002,
99:1053-1059.
23. Cecchini S, Iossa A, Ciatto S, Bonardi L, Confortini M, Cipparrone G:
Colposcopic survey of Papanicolaou test-negative cases with
hyperkeratosis or parakeratosis.  Obstet Gynecol 1990,
76:857-859.
24. Zahn CM, Askew AW, Hall KL, Barth WHJ: The significance of
hyperkeratosis/parakeratosis on otherwise normal Papani-
colaou smears. Am J Obstet Gynecol 2002, 187:997-1001.
25. Leiman G: Anal sreening cytology. Cytojournal 2005, 2:5.